Neuroendocrine Factors in Melanoma Pathogenesis

Area of Science:

• Oncology
• Neuroendocrinology
• Dermatology

Background:

• Melanoma incidence is rising, particularly in young individuals, highlighting its public health significance.
• Emerging research in molecular signaling and receptor modulation offers new therapeutic avenues for melanoma.
• Stress exposure modulates the immune-inflammatory response, influencing melanoma progression via neuroendocrine factors.

Purpose of the Study:

• To review current evidence on the complex roles of neuroendocrine factors in melanoma.
• To explore the mechanisms, signaling pathways, and effects of these factors in melanoma progression.
• To incorporate findings from recent clinical trials into the understanding of neuroendocrine influence on melanoma.

Main Methods:

• Comprehensive literature review of in vitro and in vivo studies.
• Analysis of experimental data on neurotransmitters and neurohormones in melanoma.
• Inclusion of data from recent clinical trials investigating neuroendocrine modulators.

Main Results:

• Neurotransmitters (catecholamines, glutamate, serotonin, cannabinoids) are implicated in melanoma biology.
• Neurohormones (alpha-MSH) and neuropeptides (substance P, CGRP, endorphins) play roles in melanoma development and metastasis.
• Cellular agents like mast cells and nitric oxide are also involved in melanoma progression.

Conclusions:

• Neuroendocrine factors are critical regulators of melanoma development, invasion, and dissemination.
• Understanding these intricate effects provides a basis for developing targeted melanoma therapies.
• Further research into neuroendocrine pathways may unlock innovative treatment strategies for melanoma.